{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T21:00:28Z","timestamp":1768251628937,"version":"3.49.0"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,2]]},"abstract":"<jats:sec>\n            <jats:title>Background.<\/jats:title>\n            <jats:p>Safely increasing organ donation to meet need is a priority. Potential donors may be declined because of perceived blood-borne virus (BBV) transmission risk. With hepatitis C (HCV) curative therapy, more potential donors may now be suitable. We sought to describe potential deceased donors with increased BBV transmission risk.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods.<\/jats:title>\n            <jats:p>We conducted a cohort study of all potential organ donors referred in NSW, Australia, 2010\u20132018. We compared baseline risk potential donors to potential donors with increased BBV transmission risk, due to history of HIV, HCV or hepatitis B, and\/or behavioral risk factors.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results.<\/jats:title>\n            <jats:p>There were 624 of 5749 potential donors (10.9%) perceived to have increased BBV transmission risk. This included 298 of 5749 (5.2%) with HCV (including HBV coinfections) and 239 of 5749 (4.2%) with increased risk behaviors (no known BBV). Potential donors with HCV and those with increased risk behaviors were younger and had fewer comorbidities than baseline risk potential donors (<jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.001). Many potential donors (82 with HCV, 38 with risk behaviors) were declined for donation purely because of perceived BBV transmission risk. Most were excluded before BBV testing. When potential donors with HCV did donate, they donated fewer organs than baseline risk donors (median 1 versus 3, <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.01), especially kidneys (odds ratio 0.08, <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.001) and lungs (odds ratio 0.11, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.006).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions.<\/jats:title>\n            <jats:p>Many potential donors were not accepted because of perceived increased BBV transmission risk, without viral testing, and despite otherwise favorable characteristics. Transplantation could be increased from potential donors with HCV and\/or increased risk behaviors.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/tp.0000000000003715","type":"journal-article","created":{"date-parts":[[2021,3,3]],"date-time":"2021-03-03T09:30:46Z","timestamp":1614763846000},"page":"348-357","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["Characteristics and Donation Outcomes of Potential Organ Donors Perceived to Be at Increased Risk for Blood-borne Virus Transmission: An Australian Cohort Study 2010\u20132018"],"prefix":"10.1097","volume":"106","author":[{"given":"Karen M.J.","family":"Waller","sequence":"first","affiliation":[{"name":"Centre for Organ Donation Evidence, Sydney School of Public Health, Faculty of Health and Medicine, The University of Sydney, Camperdown, NSW, Australia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole L.","family":"De La Mata","sequence":"additional","affiliation":[{"name":"Centre for Organ Donation Evidence, Sydney School of Public Health, Faculty of Health and Medicine, The University of Sydney, Camperdown, NSW, Australia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brenda M.","family":"Rosales","sequence":"additional","affiliation":[{"name":"Centre for Organ Donation Evidence, Sydney School of Public Health, Faculty of Health and Medicine, The University of Sydney, Camperdown, NSW, Australia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James A.","family":"Hedley","sequence":"additional","affiliation":[{"name":"Centre for Organ Donation Evidence, Sydney School of Public Health, Faculty of Health and Medicine, The University of Sydney, Camperdown, NSW, Australia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick J.","family":"Kelly","sequence":"additional","affiliation":[{"name":"Centre for Organ Donation Evidence, Sydney School of Public Health, Faculty of Health and Medicine, The University of Sydney, Camperdown, NSW, Australia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Imogen K.","family":"Thomson","sequence":"additional","affiliation":[{"name":"Centre for Organ Donation Evidence, Sydney School of Public Health, Faculty of Health and Medicine, The University of Sydney, Camperdown, NSW, Australia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J.","family":"O\u2019Leary","sequence":"additional","affiliation":[{"name":"NSW Organ and Tissue Donation Service, Kogarah, NSW, Australia."},{"name":"Intensive Care Service, Royal Prince Alfred Hospital, Camperdown, NSW, Australia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Cavazzoni","sequence":"additional","affiliation":[{"name":"NSW Organ and Tissue Donation Service, Kogarah, NSW, Australia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vidiya","family":"Ramachandran","sequence":"additional","affiliation":[{"name":"Serology and Virology Division, NSW Health Pathology, Prince of Wales Hospital, Randwick, NSW, Australia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William D.","family":"Rawlinson","sequence":"additional","affiliation":[{"name":"Serology and Virology Division, NSW Health Pathology, Prince of Wales Hospital, Randwick, NSW, Australia."},{"name":"Schools of SOMS, BABS and Women\u2019s and Children\u2019s, University of NSW, Randwick, NSW, Australia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kate R.","family":"Wyburn","sequence":"additional","affiliation":[{"name":"Department of Renal Medicine, Royal Prince Alfred Hospital, Camperdown, NSW, Australia."},{"name":"Sydney Medical School, Faculty of Medicine and Health, The University of Sydney, Camperdown, NSW, Australia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela C.","family":"Webster","sequence":"additional","affiliation":[{"name":"Centre for Organ Donation Evidence, Sydney School of Public Health, Faculty of Health and Medicine, The University of Sydney, Camperdown, NSW, Australia."},{"name":"Centre for Transplant and Renal Research, Westmead Hospital, Westmead, NSW, Australia."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2022,1,31]]},"reference":[{"key":"R1-20250607","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1056\/NEJMe1901957","article-title":"Organs from hepatitis C virus\u2013positive donors.","volume":"380","author":"Blumberg","year":"2019","journal-title":"N Eng J Med"},{"key":"R4-20250607","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/TP.0000000000000251","article-title":"Guidance on the use of increased infectious risk donors for organ transplantation.","volume":"98","year":"2014","journal-title":"Transplantation"},{"key":"R5-20250607","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1111\/ajt.15231","article-title":"Kidney transplant outcomes associated with the use of increased risk donors in children.","volume":"19","author":"Kizilbash","year":"2018","journal-title":"Am J Transplant"},{"key":"R6-20250607","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/ajt.14577","article-title":"Turn down for what? Patient outcomes associated with declining increased infectious risk kidneys.","volume":"18","author":"Bowring","year":"2018","journal-title":"Am J Transplant"},{"key":"R7-20250607","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1056\/NEJMoa1812406","article-title":"Heart and lung transplants from HCV-infected donors to uninfected recipients.","volume":"380","author":"Woolley","year":"2019","journal-title":"N Engl J Med"},{"key":"R8-20250607","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1097\/TP.0000000000002033","article-title":"Use of organs from hepatitis C virus-positive donors for uninfected recipients: a potential cost-effective approach to save lives?","volume":"102","author":"Trotter","year":"2018","journal-title":"Transplantation"},{"key":"R9-20250607","doi-asserted-by":"crossref","first-page":"273","DOI":"10.7326\/M18-0749","article-title":"Twelve-month outcomes after transplant of hepatitis C-infected kidneys into uninfected recipients: a single-group trial.","volume":"169","author":"Reese","year":"2018","journal-title":"Ann Intern Med"},{"key":"R15-20250607","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1097\/TP.0000000000001727","article-title":"Deceased organ donors with a history of increased risk behavior for the transmission of blood-borne viral infection: the UK experience.","volume":"101","author":"Trotter","year":"2017","journal-title":"Transplantation"},{"key":"R16-20250607","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1097\/TP.0000000000001716","article-title":"Deceased organ donors and PHS risk identification: impact on organ usage and outcomes.","volume":"101","author":"Pruett","year":"2017","journal-title":"Transplantation"},{"key":"R17-20250607","doi-asserted-by":"crossref","first-page":"e504","DOI":"10.1097\/TXD.0000000000000938","article-title":"Epidemiology and comorbidity burden of organ donor referrals in Australia: cohort study 2010\u20132015.","volume":"5","author":"Thomson","year":"2019","journal-title":"Transplantation Direct"},{"issue":"suppl 1","key":"R20-20250607","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/ajt.15678","article-title":"OPTN\/SRTR 2018 annual data report: deceased organ donation.","volume":"20","author":"Israni","year":"2020","journal-title":"Am J Transplant"},{"key":"R21-20250607","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1097\/TP.0000000000001885","article-title":"Hepatitis transmission risk in kidney transplantation (the HINT study): a cross-sectional survey of transplant clinicians in Australia and New Zealand.","volume":"102","author":"Waller","year":"2018","journal-title":"Transplantation"},{"key":"R25-20250607","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1177\/003335491312800403","article-title":"PHS guideline for reducing human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission through organ transplantation.","volume":"128","author":"Seem","year":"2013","journal-title":"Public Health Rep"},{"key":"R26-20250607","doi-asserted-by":"crossref","first-page":"61","DOI":"10.15585\/mmwr.mm6803a2","article-title":"Characteristics of deceased solid organ donors and screening results for hepatitis B, C, and human immunodeficiency viruses \u2014 United States, 2010\u20132017.","volume":"68","author":"Abara","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R28-20250607","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0140-6736(12)61685-7","article-title":"Effect of donor age and cold storage time on outcome in recipients of kidneys donated after circulatory death in the UK: a cohort study.","volume":"381","author":"Summers","year":"2013","journal-title":"Lancet"},{"key":"R29-20250607","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1111\/jocs.12406","article-title":"Impact of donor age on survival after heart transplantation: an analysis of the United Network for Organ Sharing (UNOS) registry.","volume":"29","author":"Weber","year":"2014","journal-title":"J Card Surg"},{"key":"R30-20250607","doi-asserted-by":"crossref","first-page":"4966","DOI":"10.3748\/wjg.v22.i21.4966","article-title":"How important is donor age in liver transplantation?","volume":"22","author":"Lu\u00e9","year":"2016","journal-title":"World J Gastroenterol"},{"key":"R31-20250607","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.exger.2018.06.019","article-title":"The effects of donor age on organ transplants: a review and implications for aging research.","volume":"110","author":"Dayoub","year":"2018","journal-title":"Exp Gerontol"},{"key":"R32-20250607","doi-asserted-by":"crossref","first-page":"414","DOI":"10.5694\/mja2.50315","article-title":"Residual risk of infection with blood-borne viruses in potential organ donors at increased risk of infection: systematic review and meta-analysis.","volume":"211","author":"Waller","year":"2019","journal-title":"Med J Aust"},{"key":"R33-20250607","doi-asserted-by":"crossref","first-page":"e13437","DOI":"10.1111\/tid.13437","article-title":"New blood-borne virus infections among organ transplant recipients: an Australian data-linked cohort study examining donor transmissions and other HIV, hepatitis C and hepatitis B notifications, 2000-2015.","volume":"22","author":"Waller","year":"2020","journal-title":"Transpl Infect Dis"},{"key":"R34-20250607","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1681\/ASN.2017080853","article-title":"HIV-positive kidney donor aelection for HIV-positive transplant recipients.","volume":"29","author":"Muller","year":"2018","journal-title":"J Am Soc Nephrol"},{"key":"R35-20250607","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1007\/s11904-019-00460-7","article-title":"HIV and solid organ transplantation: where are we now.","volume":"16","author":"Botha","year":"2019","journal-title":"Curr HIV\/AIDS Rep"},{"key":"R36-20250607","doi-asserted-by":"crossref","first-page":"62","DOI":"10.3390\/diseases6030062","article-title":"Underutilization of hepatitis C virus seropositive donor kidneys in the united states in the current opioid epidemic and direct-acting antiviral era.","volume":"6","author":"Li","year":"2018","journal-title":"Diseases"},{"key":"R37-20250607","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1159\/000486516","article-title":"Effect of the opioid crisis on the donor pool for kidney transplantation: an analysis of national kidney deceased donor trends from 2010-2016.","volume":"47","author":"Chute","year":"2018","journal-title":"Am J Nephrol"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000003715","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T16:09:53Z","timestamp":1749312593000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000003715"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,31]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000003715","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1,31]]}}}